miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway

Frontiers in Cellular Neuroscience

Volumn 8, Issue JULY, 2014, Pages

  Fragkouli, Apostolia ^a   Doxakis, Epaminondas ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

miR 153; miR 7; mTOR; Neuron; Neuroprotection; Parkinson's disease; Rapamycin

Indexed keywords

1 METHYL 4 PHENYL PYRIDINIUM; ALPHA SYNUCLEIN; CASPASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 153; MICRORNA 7; MITOGEN ACTIVATED PROTEIN KINASE 14; NEUROTOXIN; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P70; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; MAP KINASE ASSAY; MOUSE; MTT ASSAY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; UPREGULATION;

EID: 84903768917     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00182     Document Type: Article

References (99)

1. Ballard, P. A., Tetrud, J. W., and Langston, J. W. (1985). Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35, 949-956. doi: 10.1212/WNL.35.7.949
2. Bao, X. Q., Kong, X. C., Qian, C., and Zhang, D. (2012). FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. Neuroscience 202, 396-404. doi: 10.1016/j.neuroscience.2011.11.036
3. Barnat, M., Enslen, H., Propst, F., Davis, R. J., Soares, S., and Nothias, F. (2010). Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. J. Neurosci. 30, 7804-7816. doi: 10.1523/JNEUROSCI.0372-10.2010
4. Bjorkblom, B., Ostman, N., Hongisto, V., Komarovski, V., Filen, J. J., Nyman, T. A., et al. (2005). Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J. Neurosci. 25, 6350-6361. doi: 10.1523/JNEUROSCI.1517-05.2005
5. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M. E. (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms. Science 286, 1358-1362. doi: 10.1126/science.286.5443.1358
6. Braak, H., Rub, U., Schultz, C., and Del Tredici, K. (2006). Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J. Alzheimers Dis. 9, 35-44.
7. Campbell, D. S., and Holt, C. E. (2001). Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32, 1013-1026. doi: 10.1016/S0896-6273(01)00551-7
8. +-induced neurodegeneration. J. Neurochem. 115, 247-258. doi: 10.1111/j.1471-4159.2010.06924.x
9. Chen, J. T., Lu, D. H., Chia, C. P., Ruan, D. Y., Sabapathy, K., and Xiao, Z. C. (2005). Impaired long-term potentiation in c-Jun N-terminal kinase 2-deficient mice. J. Neurochem. 93, 463-473. doi: 10.1111/j.1471-4159.2005.03037.x
10. Chen, X. G., Liu, F., Song, X. F., Wang, Z. H., Dong, Z. Q., Hu, Z. Q., et al. (2010). Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways. Mol. Carcinog. 49, 603-610. doi: 10.1002/mc.20628
11. Chung, J. Y., Lee, S. J., Lee, S. H., Jung, Y. S., Ha, N. C., Seol, W., et al. (2011). Direct interaction of alpha-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease. Neurosignals 19, 86-96. doi: 10.1159/000325028
12. +-induced neuronal apoptosis. Neurochem. Int. 59, 945-953. doi: 10.1016/j.neuint.2011.07.005
13. Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X. M., Ou, C. C., et al. (2002). Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277, 35364-35370. doi: 10.1074/jbc.M205838200
14. Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., et al. (1979). Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249-254. doi: 10.1016/0165-1781(79)90006-4
15. +-induced alteration of translational control in Neuro-2a neuroblastoma cells. J. Neurosci. Res. 85, 2017-2025. doi: 10.1002/jnr.21318
16. Doxakis, E. (2010). Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem. 285, 12726-12734. doi: 10.1074/jbc.M109.086827
17. Doxakis, E. (2013). Principles of miRNA-Target Regulation in Metazoan Models. Int. J. Mol. Sci. 14, 16280-16302. doi: 10.3390/ijms140816280
18. Doxakis, E., Huang, E. J., and Davies, A. M. (2004). Homeodomain-interacting protein kinase-2 regulates apoptosis in developing sensory and sympathetic neurons. Curr. Biol. 14, 1761-1765. doi: 10.1016/j.cub.2004.09.050
19. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., et al. (2008a). LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899. doi: 10.1038/nature06783
20. Elmen, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., et al. (2008b). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153-1162. doi: 10.1093/nar/gkm1113
21. Fang, Y., Xue, J. L., Shen, Q., Chen, J., and Tian, L. (2012). MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 55, 1852-1862. doi: 10.1002/hep.25576
22. Hashimoto, R., Yu, J., Koizumi, H., Ouchi, Y., and Okabe, T. (2012). Ginsenoside Rb1 Prevents MPP(+)-Induced Apoptosis in PC12 Cells by Stimulating Estrogen Receptors with Consequent Activation of ERK1/2, Akt and Inhibition of SAPK/JNK, p38 MAPK. Evid. Based Complement. Alternat. Med. 2012, 693717. doi: 10.1155/2012/693717
23. Hentges, K. E., Sirry, B., Gingeras, A. C., Sarbassov, D., Sonenberg, N., Sabatini, D., et al. (2001). FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse. Proc. Natl. Acad. Sci. U.S.A. 98, 13796-13801. doi: 10.1073/pnas.241184198
24. Hubner, A., Barrett, T., Flavell, R. A., and Davis, R. J. (2008). Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol. Cell 30, 415-425. doi: 10.1016/j.molcel.2008.03.025
25. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648-657. doi: 10.1038/ncb839
26. Jaworski, J., Spangler, S., Seeburg, D. P., Hoogenraad, C. C., and Sheng, M. (2005). Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci. 25, 11300-11312. doi: 10.1523/JNEUROSCI.2270-05.2005
27. Jia, G., Cheng, G., Gangahar, D. M., and Agrawal, D. K. (2006). Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol. Cell Biol. 84, 448-454. doi: 10.1111/j.1440-1711.2006.01454.x
28. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W., Im, J. Y., and Mouradian, M. M. (2009). Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. U.S.A. 106, 13052-13057. doi: 10.1073/pnas.0906277106
29. +-induced apoptosis in neurons. Neurochem. Int. 57, 774-782. doi: 10.1016/j.neuint.2010.08.015
30. Karunakaran, S., Saeed, U., Mishra, M., Valli, R. K., Joshi, S. D., Meka, D. P., et al. (2008). Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. J. Neurosci. 28, 12500-12509. doi: 10.1523/JNEUROSCI.4511-08.2008
31. Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., et al. (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68, 3566-3572. doi: 10.1158/0008-5472.CAN-07-6639
32. Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
33. Kordower, J. H., and Bjorklund, A. (2013). Trophic factor gene therapy for Parkinson's disease. Mov. Disord. 28, 96-109. doi: 10.1002/mds.25344
34. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al. (2005). Silencing of microRNAs in vivo with antagomirs. Nature 438, 685-689. doi: 10.1038/nature04303
35. Kumar, V., Zhang, M. X., Swank, M. W., Kunz, J., and Wu, G. Y. (2005). Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 25, 11288-11299. doi: 10.1523/JNEUROSCI.2284-05.2005
36. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980. doi: 10.1126/science.6823561
37. Langston, J. W., Irwin, I., Langston, E. B., and Forno, L. S. (1984). 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48, 87-92. doi: 10.1016/0304-3940(84)90293-3
38. Laplante, M., and Sabatini, D. M. (2013). Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell Sci. 126, 1713-1719. doi: 10.1242/jcs.125773
39. Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170. doi: 10.1016/0306-4522(90)90229-W
40. Li, Y. H., Werner, H., and Puschel, A. W. (2008). Rheb and mTOR regulate neuronal polarity through Rap1B. J. Biol. Chem. 283, 33784-33792. doi: 10.1074/jbc.M802431200
41. Liang, Y., Ridzon, D., Wong, L., and Chen, C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166. doi: 10.1186/1471-2164-8-166
42. Lindow, M., and Kauppinen, S. (2012). Discovering the first microRNA-targeted drug. J. Cell Biol. 199, 407-412. doi: 10.1083/jcb.201208082
43. Long, J. M., Ray, B., and Lahiri, D. K. (2012). MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J. Biol. Chem. 287, 31298-31310. doi: 10.1074/jbc.M112.366336
44. Malagelada, C., Ryu, E. J., Biswas, S. C., Jackson-Lewis, V., and Greene, L. A. (2006). RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J. Neurosci. 26, 9996-10005. doi: 10.1523/JNEUROSCI.3292-06.2006
45. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., and Cantley, L. C. (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151-162. doi: 10.1016/S1097-2765(02)00568-3
46. Mizuno, Y., Sone, N., and Saitoh, T. (1987). Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J. Neurochem. 48, 1787-1793. doi: 10.1111/j.1471-4159.1987.tb05737.x
47. Morfini, G. A., You, Y. M., Pollema, S. L., Kaminska, A., Liu, K., Yoshioka, K., et al. (2009). Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 12, 864-871. doi: 10.1038/nn.2346
48. Mouradian, M. M. (2012). MicroRNAs in Parkinson's disease. Neurobiol. Dis. 46, 279-284. doi: 10.1016/j.nbd.2011.12.046
49. Mythri, R. B., Harish, G., and Bharath, M. M. (2012). Therapeutic potential of natural products in Parkinson's disease. Recent. Pat. Endocr. Metab. Immune Drug Discov. 6, 181-200. doi: 10.2174/187221412802481793
50. Nakaso, K., Ito, S., and Nakashima, K. (2008). Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146-150. doi: 10.1016/j.neulet.2007.12.034
51. Nicklas, W. J., Vyas, I., and Heikkila, R. E. (1985). Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 2503-2508. doi: 10.1016/0024-3205(85)90146-8
52. Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., et al. (2010). Missing pieces in the Parkinson's disease puzzle. Nat. Med. 16, 653-661. doi: 10.1038/nm.2165
53. Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., et al. (2008). Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963-966. doi: 10.1126/science.1161566
54. Piao, Y., Kim, H. G., Oh, M. S., and Pak, Y. K. (2012). Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells. Biochim. Biophys. Acta 1820, 577-585. doi: 10.1016/j.bbagen.2011.08.007
55. Podkowa, M., Zhao, X., Chow, C. W., Coffey, E. T., Davis, R. J., and Attisano, L. (2010). Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol. Cell Biol. 30, 2241-2250. doi: 10.1128/MCB.01166-09
56. Reinhard, J. F. Jr. Daniels, A. J., and Painter, G. R. (1990). Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization. Biochem. Biophys. Res. Commun. 168, 1143-1148. doi: 10.1016/0006-291X(90)91148-L
57. Reinhardt, P., Schmid, B., Burbulla, L. F., Schondorf, D. C., Wagner, L., Glatza, M., et al. (2013). Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354-367. doi: 10.1016/j.stem.2013.01.008
58. Rodnitzky, R. L. (2012). Upcoming treatments in Parkinson's disease, including gene therapy. Parkinsonism Relat. Disord. 18(Suppl. 1), S37-S40. doi: 10.1016/S1353-8020(11)70014-1
59. Rodriguez-Blanco, J., Martin, V., Garcia-Santos, G., Herrera, F., Casado-Zapico, S., Antolin, I., et al. (2012). Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells. J. Neurosci. Res. 90, 1850-1860. doi: 10.1002/jnr.23066
60. Rosner, M., and Hengstschlager, M. (2008). Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet. 17, 2934-2948. doi: 10.1093/hmg/ddn192
61. Runden, E., Seglen, P. O., Haug, F. M., Ottersen, O. P., Wieloch, T., Shamloo, M., et al. (1998). Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 7296-7305.
62. Russ, H., Staust, K., Martel, F., Gliese, M., and Schomig, E. (1996). The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur. J. Neurosci. 8, 1256-1264. doi: 10.1111/j.1460-9568.1996.tb01294.x
63. Sanchez, N., Gallagher, M., Lao, N., Gallagher, C., Clarke, C., Doolan, P., et al. (2013). MiR-7 triggers cell cycle arrest at the G1/S transition by targeting multiple genes including Skp2 and Psme3. PLoS ONE 8:e65671. doi: 10.1371/journal.pone.0065671
64. Santos, C. M. (2012). New agents promote neuroprotection in Parkinson's disease models. CNS Neurol. Disord. Drug Targets 11, 410-418. doi: 10.2174/187152712800792820
65. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., et al. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168. doi: 10.1016/j.molcel.2006.03.029
66. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101. doi: 10.1126/science.1106148
67. Satoh, T., Nakatsuka, D., Watanabe, Y., Nagata, I., Kikuchi, H., and Namura, S. (2000). Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 288, 163-166. doi: 10.1016/S0304-3940(00)01229-5
68. Seidl, S. E., and Potashkin, J. A. (2011). The promise of neuroprotective agents in Parkinson's disease. Front. Neurol. 2:68. doi: 10.3389/fneur.2011.00068
69. Song, L., Duan, P., Guo, P., Li, D., Li, S., Xu, Y., et al. (2012). Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor. Arch Biochem. Biophys. 528, 204-211. doi: 10.1016/j.abb.2012.08.015
70. Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., et al. (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275, 12200-12206. doi: 10.1074/jbc.275.16.12200
71. Sun, D. S., and Chang, H. H. (2003). Differential regulation of JNK in caspase-3-mediated apoptosis of MPP(+)-treated primary cortical neurons. Cell Biol. Int. 27, 769-777. doi: 10.1016/S1065-6995(03)00165-3
72. Swiech, L., Perycz, M., Malik, A., and Jaworski, J. (2008). Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116-132. doi: 10.1016/j.bbapap.2007.08.015
73. Takei, N., Kawamura, M., Ishizuka, Y., Kakiya, N., Inamura, N., Namba, H., et al. (2009). Brain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neurons. J. Biol. Chem. 284, 26340-26348. doi: 10.1074/jbc.M109.023010
74. Tararuk, T., Ostman, N., Li, W., Bjorkblom, B., Padzik, A., Zdrojewska, J., et al. (2006). JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J. Cell Biol. 173, 265-277. doi: 10.1083/jcb.200511055
75. Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., and Sabatini, B. L. (2005). Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727-1734. doi: 10.1038/nn1566
76. Thomas, G. M., Lin, D. T., Nuriya, M., and Huganir, R. L. (2008a). Rapid and bi-directional regulation of AMPA receptor phosphorylation and trafficking by JNK. EMBO J. 27, 361-372. doi: 10.1038/sj.emboj.7601969
77. Thomas, T., Timmer, M., Cesnulevicius, K., Hitti, E., Kotlyarov, A., and Gaestel, M. (2008b). MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation-relevance in a mouse model of Parkinson's disease. J. Neurochem. 105, 2039-2052. doi: 10.1111/j.1471-4159.2008.05310.x
78. Timmons, S., Coakley, M. F., Moloney, A. M., and O'Neill, C. (2009). Akt signal transduction dysfunction in Parkinson's disease. Neurosci. Lett. 467, 30-35. doi: 10.1016/j.neulet.2009.09.055
79. Trojanowski, J. Q., Goedert, M., Iwatsubo, T., and Lee, V. M. (1998). Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ. 5, 832-837. doi: 10.1038/sj.cdd.4400432
80. Van der Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J., and Kim, D. H. (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323. doi: 10.1038/ncb1547
81. Verma, P., Chierzi, S., Codd, A. M., Campbell, D. S., Meyer, R. L., Holt, C. E., et al. (2005). Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration. J. Neurosci. 25, 331-342. doi: 10.1523/JNEUROSCI.3073-04.2005
82. Wang, G., Pan, J., and Chen, S. D. (2012). Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease. Prog. Neurobiol. 98, 207-221. doi: 10.1016/j.pneurobio.2012.06.003
83. +-induced apoptosis by AKT/GSK-3beta/JNK signaling. Apoptosis 15, 1470-1479. doi: 10.1007/s10495-010-0547-z
84. Wang, Y., Liu, J., Liu, C., Naji, A., and Stoffers, D. A. (2013). MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells. Diabetes 62, 887-895. doi: 10.2337/db12-0451
85. Wienholds, E., and Plasterk, R. H. (2005). MicroRNA function in animal development. FEBS Lett. 579, 5911-5922. doi: 10.1016/j.febslet.2005.07.070
86. Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., et al. (2007). Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859. doi: 10.1126/science.1133289
87. Wu, D. C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., et al. (2003). NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 6145-6150. doi: 10.1073/pnas.0937239100
88. Wu, X., Reiter, C. E., Antonetti, D. A., Kimball, S. R., Jefferson, L. S., and Gardner, T. W. (2004). Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J. Biol. Chem. 279, 9167-9175. doi: 10.1074/jbc.M312397200
89. Wu, Z., He, B., He, J., and Mao, X. (2013). Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate 73, 596-604. doi: 10.1002/pros.22600
90. Xu, P., Das, M., Reilly, J., and Davis, R. J. (2011). JNK regulates FoxO-dependent autophagy in neurons. Genes Dev. 25, 310-322. doi: 10.1101/gad.1984311
91. Yuan, Y., Sun, J., Zhao, M., Hu, J., Wang, X., Du, G., et al. (2010). Overexpression of alpha-synuclein down-regulates BDNF expression. Cell. Mol. Neurobiol. 30, 939-946. doi: 10.1007/s10571-010-9523-y
92. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873. doi: 10.1038/nrn1537
93. Zhang, K., Ma, Z., Wang, J., Xie, A., and Xie, J. (2011). Myricetin attenuated MPP(+)-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells. Neuropharmacology 61, 329-335. doi: 10.1016/j.neuropharm.2011.04.021
94. Zhu, J. H., Guo, F., Shelburne, J., Watkins, S., and Chu, C. T. (2003). Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol. 13, 473-481. doi: 10.1111/j.1750-3639.2003.tb00478.x
95. + toxicity: dual roles for ERK1/2. Cell Death Dis. 3, e312. doi: 10.1038/cddis.2012.46
96. Zhu, J. H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y., and Chu, C. T. (2007). Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 170, 75-86. doi: 10.2353/ajpath.2007.060524
97. Zhu, J. H., Kulich, S. M., Oury, T. D., and Chu, C. T. (2002). Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am. J. Pathol. 161, 2087-2098. doi: 10.1016/S0002-9440(10)64487-2
98. Zhu, Y., Pak, D., Qin, Y., McCormack, S. G., Kim, M. J., Baumgart, J. P., et al. (2005). Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46, 905-916. doi: 10.1016/j.neuron.2005.04.037
99. Zigmond, M. J., Hastings, T. G., and Perez, R. G. (2002). Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? Parkinsonism Relat. Disord. 8, 389-393. doi: 10.1016/S1353-8020(02)00019-6